Simplera Sync
Medtronic MiniMed, Inc. · Decision date Jul 21, 2026
What did the FDA decide?
FDA records P250012/S011 as a supplement to PMA P250012, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 21, 2026.
FDA approval order statement
undefined
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Clinical Chemistry
- Decision date
- Jul 21, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P250012/S011
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic MiniMed, Inc.
- Product code
- SFI
- Decision code
- OK30
- Decision date
- Jul 21, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Sensor, Glucose, Invasive, Component of automated insulin delivery system.
- Applicant
- Medtronic MiniMed, Inc.
- Product code
- SFI
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P250012. Subsequent supplements may change the device or its indications.
FDA decision timeline
P250012 · Original PMA
Simplera Sync Sensor, Guardian 4 Sensor
P250012/S001 · Related supplement
Simplera Sync Sensor, Guardian 4 Sensor
P250012/S003 · Related supplement
Simplera Sync Sensor, Guardian 4 Sensor
P250012/S002 · Related supplement
Guardian 4 Sensor
P250012/S004 · Related supplement
Simplera Sync Sensor, Guardian 4 Sensor
P250012/S006 · Related supplement
Simplera Sync Sensor
P250012/S007 · Related supplement
Simplera Sync Sensor
P250012/S005 · Related supplement
Simplera Sync Sensor; Guardian 4 Sensor
P250012/S009 · Related supplement
Simplera Sync Sensor
P250012/S010 · Related supplement
Simplera and Simplera Sync
P250012/S008 · Related supplement
Simplera Sync Sensor
P250012/S011 received
Application receipt date recorded by FDA.
P250012/S011 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P250012. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P250012
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic MiniMed, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 18000 Devonshire St., Northridge, CA, 91325
Sources and methodology
- Original FDA record: P250012/S011
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






